183 related articles for article (PubMed ID: 2922381)
1. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Rühl GH; Börsch G
Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
[No Abstract] [Full Text] [Related]
2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
4. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
Menge H; Hofmann J; Gregor M
Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
[No Abstract] [Full Text] [Related]
5. [Campylobacter pylori associated gastritis].
Internist (Berl); 1989 Dec; 30(12):830-2. PubMed ID: 2621061
[No Abstract] [Full Text] [Related]
6. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
7. [Classic triple therapy for Helicobacter pylori infection].
Takahashi S; Tanaka A
Nihon Rinsho; 2002 Feb; 60 Suppl 2():420-2. PubMed ID: 11979818
[No Abstract] [Full Text] [Related]
8. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
[TBL] [Abstract][Full Text] [Related]
9. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
10. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Campylobacter pylori does not alter gastric acid secretion.
Montbriand JR; Appelman HD; Cotner EK; Nostrant TT; Elta GH
Am J Gastroenterol; 1989 Dec; 84(12):1513-6. PubMed ID: 2596452
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
Andreasen JJ; Ringsdal VS
Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
López-Brea M; Alarcón T
Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
[No Abstract] [Full Text] [Related]
14. [Search for the best procedure for Campylobacter eradication. Results of long-term studies are still unavailable].
Börsch G
Fortschr Med; 1989 Jul; 107(22):471-2. PubMed ID: 2793022
[No Abstract] [Full Text] [Related]
15. [Campylobacter pylori and therapy with bismuth salts].
Börsch G
Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
[No Abstract] [Full Text] [Related]
16. Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Maniatis AG; Brazer SR
Am J Gastroenterol; 1994 Jun; 89(6):947-8. PubMed ID: 8198114
[No Abstract] [Full Text] [Related]
17. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
[TBL] [Abstract][Full Text] [Related]
19. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
Lanza FL; Skoglund ML; Rack MF; Yardley JH
Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
[TBL] [Abstract][Full Text] [Related]
20. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
